Thousands of people living with advanced prostate cancer will have access to a life-extending new treatment that can be taken at home from today, the UK health technology assessor, National Institute ...
Canadian pharma company Bausch Health has announced the results of the global Phase III RED-C clinical program.
South Korea’s Samsung Bioepis today released its first quarter 2026 biosimilar market report, marking the twelfth edition of ...
Australian biotech Neurizon Therapeutics (ASX: NUZ) is setting out to redefine how neurodegenerative diseases are treated, ...
The USA has completed its withdrawal from the World Health Organization (WHO), according to a joint announcement by the US ...
In a new report, DelveInsight argues the gastroesophageal reflux disease market remains constrained by limited approved ...
The Russian government has extended the permit for domestic pharmaceutical companies Promomed and PSK Pharma to produce ...
Sun Pharmaceutical Industries has received approval from the Drugs Controller General of India (DCGI) to manufacture and ...
Japanese pharma Daiichi Sankyo (TSE: 4568) and British partner AstraZeneca (LSE: AZN) said Enhertu (trastuzumab deruxtecan) ...
US biopharma Corcept Therapeutics (Nasdaq: CORT) says its Phase III ROSELLA trial met its overall survival primary endpoint ...
Japanese drugmaker Daiichi Sankyo has appointed Veronika Rozehnal to succeed Jürgen Müller as the Head of the Translational ...
Janux Therapeutics’ shares closed up 14% at $15.14, after it announced a collaboration and exclusive worldwide license ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback